Tocilizumab and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with tocilizumab.
Tocilizumab High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Moderate Potential Hazard, Moderate plausibility
tocilizumab - lipid abnormalities
Tocilizumab treatment was associated with increases in lipid parameters (e.g., total cholesterol, triglycerides, low-density lipoprotein [LDL] cholesterol, and/or high-density lipoprotein [HDL] cholesterol). Lipid parameters should be assessed about 4 to 8 weeks after initiation of therapy. Patients should be managed according to clinical guidelines for the management of hyperlipidemia.
References (1)
- (2022) "Product Information. Actemra (tocilizumab)." Genentech, SUPPL-138/SUPPL-49
Switch to consumer interaction data
Tocilizumab drug interactions
There are 427 drug interactions with tocilizumab.
Tocilizumab disease interactions
There are 8 disease interactions with tocilizumab which include:
- infections
- tuberculosis
- demyelinating disorders
- gastrointestinal perforation
- lipid abnormalities
- liver dysfunction
- neutropenia/thrombocytopenia
- renal impairment
More about tocilizumab
- tocilizumab consumer information
- Check interactions
- Compare alternatives
- Reviews (57)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.